Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01218516
Previous Study | Return to List | Next Study

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

This study has been completed.
Information provided by (Responsible Party):
Morphotek Identifier:
First received: October 7, 2010
Last updated: June 16, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 25, 2015